Telesis Bio (TBIO.US): The 2024 Q1 financial report achieved revenue of US$3.44 million, with an earlier value of US$6.316 million and an expected value of US$6.9 million; earnings per share were -5.52 dollars, the previous value was -6.75 dollars, and the expected value was -4.14 dollars.
Telesis Bio(TBIO.US)：2024年Q1财报实现营收344万美元，前值为631.6万美元，预期值为690万美元；每股收益为-5.52美元，前值为-6.75美元，预期值为-4.14美元。
Telesis Bio (TBIO.US): The 2024 Q1 financial report achieved revenue of US$3.44 million, with an earlier value of US$6.316 million and an expected value of US$6.9 million; earnings per share were -5.52 dollars, the previous value was -6.75 dollars, and th
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.